Filing Details
- Accession Number:
- 0001209191-13-005987
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-04 16:27:12
- Reporting Period:
- 2013-02-01
- Filing Date:
- 2013-02-04
- Accepted Time:
- 2013-02-04 16:27:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1463321 | Susan Mahony | Lilly Corporate Center Indianapolis IN 46285 | Svp & Pres., Lilly Oncology | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-02-01 | 10,777 | $53.69 | 34,437 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2013-02-01 | 22,943 | $0.00 | 57,380 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-01 | 5,000 | $54.28 | 52,380 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2013-02-01 | 22,943 | $0.00 | 22,943 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-02-01 | 2013-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,498 | Indirect | 401(k) |
| Common Stock | 1,489 | Indirect | 401(k) - by husband |
| Common Stock | 6,218 | Indirect | by husband |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2013.
- Reporting person disclaims beneficial ownership of these shares.
Billionaire Hedge Funds
